Bristol-Myers Squibb
BMY
2,367 hedge funds and large institutions have $103B invested in Bristol-Myers Squibb in 2021 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 996 increasing their positions, 947 reducing their positions, and 118 closing their positions.
13% more call options, than puts
Call options by funds: $1.21B | Put options by funds: $1.07B
5% more repeat investments, than reductions
Existing positions increased: 996 | Existing positions reduced: 947
1% more first-time investments, than exits
New positions opened: 119 | Existing positions closed: 118
0% more funds holding
Funds holding: 2,361 → 2,367 (+6)
0.69% less ownership
Funds ownership: 73.56% → 72.87% (-0.69%)
10% less funds holding in top 10
Funds holding in top 10: 78 → 70 (-8)
30% less capital inflows, than outflows
Capital inflows: $4.46B | Capital outflows: $6.39B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$322M |
| 2 |
Goldman Sachs
New York
|
+$254M |
| 3 |
BlackRock
New York
|
+$245M |
| 4 |
JP Morgan Chase
New York
|
+$230M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$167M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$716M |
| 2 |
Janus Henderson Group
London,
|
-$470M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$384M |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$279M |
| 5 |
Bank of New York Mellon
New York
|
-$259M |
BMY Hedge Fund Activity: Q1 2021 in Review
2,367 of the 5,709 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q1 2021, worth a combined $103B — down 0.33% from $103B a quarter earlier.
Buyers outnumbered sellers: 119 funds opened new BMY positions and 118 closed out — a net gain of 1 holder — while 996 added to existing stakes and 947 trimmed.
The largest buyer was Franklin Resources, adding an estimated $322M. The largest seller was Renaissance Technologies, cutting an estimated $716M.
- 2,367 institutional investors held Bristol-Myers Squibb (BMY) as of Q1 2021, up from 2,361 in Q4 2020.
- Funds reported $103B of Bristol-Myers Squibb stock for Q1 2021, down 0.33% quarter-over-quarter.
- 119 funds opened new Bristol-Myers Squibb positions in Q1 2021 and 118 closed out, a net change of +1 holder.
- The largest Bristol-Myers Squibb buyer in Q1 2021 was Franklin Resources, an estimated $322M added.
- The largest Bristol-Myers Squibb seller in Q1 2021 was Renaissance Technologies, an estimated $716M sold.
Based on aggregated 13F filings for Q1 2021.